BioLife Solutions, Inc. (BLFS) FY2026 Q2 Balance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
BioLife Solutions, Inc. (BLFS) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$13.95 MCurrent assets$135.20 MLiabilities$27.49 MNon-current liabilities$13.54 MEquity$420.00 MAssets$447.49 MGross equity(calculated)$713.62 MNon-current assets$312.30 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSAvailable-for-sale securities, current portionInventoriesCash and cash equivalentsAccounts receivable, trade, net of allowance for credit losses of $16 and $22 as of June 30, 2026 and December 31, 2025, respectivelyPrepaid expenses and other current assetsGoodwillDeferred tax assets, netAvailable-for-sale securities, long-termProperty and equipment, netOperating lease right-of-use assets, netIntangible assets, netOther assetsAccrued expenses and other current liabilitiesLease liabilities, operating, current portionAccounts payableSales taxes payableLease liabilities, operating, long-termOther long-term liabilitiesAdditional paid-in capitalCommon stock, $0.001 par value; 150,000,000 shares authorized, 48,889,090 and 48,198,928 shares issued and outstanding, respectively, as of June 30, 2026 and December 31, 2025Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated deficitAccumulated other comprehensive (loss) income, net of taxAccrued expenses and other current liabilitiesAccrued expenses and other current liabilities$6.80 MCurrent liabilitiesCurrent liabilities$13.95 MLease liabilities, operating, current portionLease liabilities, operating, current portion$2.59 MAvailable-for-sale securities, current portionAvailable-for-sale securities, current portion$58.42 MAccounts payableAccounts payable$2.48 MCurrent assetsCurrent assets$135.20 MLiabilitiesLiabilities$27.49 MSales taxes payableSales taxes payable$2.07 MInventoriesInventories$35.59 MNon-current liabilitiesNon-current liabilities$13.54 MCash and cash equivalentsCash and cash equivalents$24.00 MEquityEquity$420.00 MLease liabilities, operating, long-termLease liabilities, operating, long-term$13.15 MAssetsAssets$447.49 MAccounts receivable, trade, net of allowance for credit losses of $16 and $22 as of June 30, 2026 and December 31, 2025, respectivelyAccounts receivable, trade, net$10.65 MOther long-term liabilitiesOther long-term liabilities$399.00 KGross equity (calculated)Gross equity(calculated)$713.62 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$6.54 MNon-current assetsNon-current assets$312.30 MGoodwillGoodwill$208.59 MDeferred tax assets, netDeferred tax assets, net$42.23 MAdditional paid-in capitalAdditional paid-in capital$713.57 MAvailable-for-sale securities, long-termAvailable-for-sale securities, long-term$30.65 MProperty and equipment, netProperty and equipment, net$15.24 MOperating lease right-of-use assets, netOperating lease right-of-use assets, net$8.64 MIntangible assets, netIntangible assets, net$3.65 MOther assetsOther assets$3.29 MCommon stock, $0.001 par value; 150,000,000 shares authorized, 48,889,090 and 48,198,928 shares issued and outstanding, respectively, as of June 30, 2026 and December 31, 2025Common stock$49.00 KAccumulated deficitAccumulated deficit−$293.41 MAccumulated other comprehensive (loss) income, net of taxAccumulated other comprehensive (loss) income, net−$211.00 K
Chart details

BioLife Solutions, Inc. (BLFS) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
447,494,000 US dollars
Current assets
135,198,000 US dollars
Non-current assets
312,296,000 US dollars
Liabilities
27,491,000 US dollars
Current liabilities
13,947,000 US dollars
Non-current liabilities
13,544,000 US dollars
Equity
420,003,000 US dollars
Available-for-sale securities, current portion
58,419,000 US dollars
Inventories
35,591,000 US dollars
Cash and cash equivalents
23,997,000 US dollars
Accounts receivable, trade, net of allowance for credit losses of $16 and $22 as of June 30, 2026 and December 31, 2025, respectively
10,652,000 US dollars
Prepaid expenses and other current assets
6,539,000 US dollars
Goodwill
208,587,000 US dollars
Deferred tax assets, net
42,233,000 US dollars
Available-for-sale securities, long-term
30,654,000 US dollars
Property and equipment, net
15,235,000 US dollars
Operating lease right-of-use assets, net
8,644,000 US dollars
Intangible assets, net
3,654,000 US dollars
Other assets
3,289,000 US dollars
Accrued expenses and other current liabilities
6,798,000 US dollars
Lease liabilities, operating, current portion
2,593,000 US dollars
Accounts payable
2,482,000 US dollars
Sales taxes payable
2,074,000 US dollars
Debt, current portion
0 US dollars
Lease liabilities, operating, long-term
13,145,000 US dollars
Other long-term liabilities
399,000 US dollars
Deferred tax liabilities
0 US dollars
Additional paid-in capital
713,571,000 US dollars
Common stock, $0.001 par value; 150,000,000 shares authorized, 48,889,090 and 48,198,928 shares issued and outstanding, respectively, as of June 30, 2026 and December 31, 2025
49,000 US dollars
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025
0 US dollars
Accumulated deficit
negative 293,406,000 US dollars
Accumulated other comprehensive (loss) income, net of tax
negative 211,000 US dollars
Gross equity (calculated)
713,620,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
BioLife Solutions, Inc. (BLFS) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!